High-sensitivity Troponin T in Acute Myocardial Infarction After Cardiac Valvular Surgery
Launched by UNIVERSITY OF VALLADOLID · Aug 4, 2015
Trial Information
Current as of May 15, 2025
Unknown status
Keywords
ClinConnect Summary
This is a longitudinal prospective observational cohort mono centre study. Hs-cTn will be measured at different point of times in adult patients undergoing heart valvular surgery with cardiopulmonary bypass (CPB) and without recent medical history of ischemic heart disease.
The study is conducted at the University Clinical Hospital of Valladolid, Spain. The Cardiac Surgery department annually performs approximately 550 cardiac surgeries with CPB in adult patients (approximately 300 heart valvular surgeries). Two operating rooms are routinely used. There is an intensive care unit (ICU) with...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Each participant must be older than 18 years.
- • Undergoing cardiac valvular surgery.
- • No recent clinical history of ischemic heart disease.
- • Each participant must voluntarily give his written informed consent.
- Exclusion Criteria:
- • Patients undergoing coronary bypass artery grafting (CABG).
- • Patients with severe or end-stage renal insufficiency.
- • Insertion of assist devices.
About University Of Valladolid
The University of Valladolid, a prestigious academic institution in Spain, is dedicated to advancing medical research and improving healthcare outcomes through rigorous clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive network of researchers, healthcare professionals, and state-of-the-art facilities to conduct innovative studies across various medical fields. Committed to ethical standards and patient safety, the University of Valladolid aims to contribute valuable insights to the scientific community and enhance clinical practices through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valladolid, , Spain
Patients applied
Trial Officials
Héctor Cubero Gallego, MD
Principal Investigator
University Clinical Hospital of Valladolid
Eduardo Tamayo Gómez, MD, PhD
Study Chair
University Clinical Hospital of Valladolid
José Alberto San Román Calvar, MD, PhD
Study Chair
University Clinical Hospital of Valladolid
José Ignacio Gómez Herreras, MD, PhD
Study Chair
University Clinical Hospital of Valladolid
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials